A Prognostic Model for Drug-induced Liver Injury in China
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Doudou Hu
Qingdao Municipal Hospital
Principal Investigator - Huahua Wang
Jiaozuo People's Hospital
Principal Investigator - Hui Wang
Jiaozuo People's Hospital
Principal Investigator - Jikang Yang
Jiaozuo People's Hospital
Principal Investigator - Juan Li
Qinghai People's Hospital
Principal Investigator - Juan Luo
Hebei CNPC Central Hospital
Principal Investigator - Liang Wang
Lanzhou University Second Hospital
Principal Investigator - Liuyi Chang
Yuncheng Central Hospital
Principal Investigator - Lu Li
Peking University Third Hospital
Principal Investigator - Lu Zhang
Beijing Ditan Hospital
Principal Investigator - Pingying Li
Qinghai People's Hospital
Principal Investigator - Qiuju Tian
The Affiliated Hospital of Qingdao University
Principal Investigator - Rongkuan Li
The Second Affiliated Hospital of Dalian Medical University
Principal Investigator - Xiaoju Liu
Qinzhou First People's Hospital
Principal Investigator - Xinyan Zhao
Beijing Friendship Hospital
Study Chair - Yu Chen
Beijing You 'an Hospital, Capital Medical University
Principal Investigator - Yuanjiao Gao
Beijing Ditan Hospital
Principal Investigator - Zhengsheng Zou
Beijing 302 Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing 302 Hospital
Beijing, Beijing Municipality, China
Recruiting - Beijing Ditan Hospital
Beijing, China
Active, not recruiting - Beijing Friendship Hospital, Capital Medical University
Beijing, China
Xinyan ZhaoRecruiting - Beijing You 'An Hospital, Capital Medical University
Beijing, China
Liwei LiuLixia QiuRecruiting - Peking University Third Hospital
Beijing, China
Active, not recruiting - the Second Affiliated Hospital of Dalian Medical University
Dalian, China
Rongkuan LiRecruiting - Qinzhou First People'S Hospital
Guangxi, China
Active, not recruiting - Hebei Cnpc Central Hospital
Hebei, China
Active, not recruiting - Jiaozuo People'S Hospital
Jiaozuo, China
Hui WangJikang YangRecruiting - the Second Hospital of Lanzhou University
Lanzhou, China
Recruiting - the Affiliated Hospital of Qingdao University
Qingdao, China
Recruiting - Qinghai People'S Hospital
Qinghai, China
Pingying LiRecruiting - Yuncheng Central Hospital
Yuncheng, China
Liuyi ChangRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 May 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2028
- Last update posted
- 22 Sept 2025
- Registered enrollment
- 3,000
- Registry id
- NCT05060289
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.